Latest First Analysis news

First Analysis, a leading venture capital investor, has made a new investment in Current Ways, a company with operations mainly in California that specializes in power conversion, communication, and battery charging applications.

Terry Kiwala and Logan Bender have joined Chicago-based First Analysis’s venture capital investment and research team.

Certify Inc., the world’s largest independent provider of travel, expense, and invoice management software, has merged with First Analysis portfolio company Chrome River Technologies, which provides cloud-based expense and invoice automation solutions for more than 1,000 organizations worldwide.

First Analysis, a leading venture capital investor, has made a new investment in Boise, Idaho, based AppDetex, leading its $10 million Series B equity financing to expand sales and marketing and to invest in product development.

First Analysis provided advisory expertise to PrescribeWellness throughout the transaction, including preparation, positioning, investor coordination and contact, due diligence and negotiation.

First Analysis acted as the exclusive financial advisor in the sale of Mirixa, a leading healthcare technology and services company specializing in medication therapy management (MTM).

First Analysis acted as the exclusive financial advisor to ClearCompany for its $60 million growth capital financing round led by Primus Capital.

First Analysis, a leading mid-stage venture capital investor, has closed on its 13th fund (First Analysis Fund XII+) at $91 million in committed capital. With the new fund, First Analysis will continue its 33-year track record in technology and healthcare investing. To date, the fund has invested in three companies.

First Analysis recently acted as co-manager for Pluralsight Inc.’s $311 million initial public offering. Pluralsight is an enterprise technology learning platform that delivers a unified, end-to-end learning experience for businesses across the globe.